Back to top

Immunomedics (IMMU) Catches Eye: Stock Moves 10.8% Higher

Read MoreHide Full Article

Immunomedics Inc. (IMMU - Free Report) was a big mover last session, as its shares rose almost 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally continues the recent uptrend for the company, as the stock is now up over 52% in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Immunomedics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is Anika Therapeutics Inc. (ANIK - Free Report) with a Zacks Rank #1 (Strong Buy).

Is IMMU going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Immunomedics, Inc. (IMMU) - free report >>

Anika Therapeutics Inc. (ANIK) - free report >>

More from Zacks Tale of the Tape

You May Like